**RFK Jr. remains HHS Secretary with strong White House backing.** President Trump has repeatedly voiced support for his health secretary, including through joint appearances and directives aligning on vaccine schedule reviews and related research priorities, even as some advisers sought to moderate messaging ahead of midterms. Kennedy continues directing departmental reorganizations, budget presentations to Congress, and policy implementation on chronic disease and preventive care without signs of resignation or removal. External calls for his departure from critics and healthcare groups have not prompted administration action, and his public statements rule out a 2028 presidential run that might otherwise create exit pressure. Trader consensus at 72% for “No” reflects these structural and political factors limiting near-term departure risk through year-end.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · Atualizado$24,323 Vol.
$24,323 Vol.
$24,323 Vol.
$24,323 Vol.
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Mercado Aberto: Mar 19, 2026, 2:02 PM ET
Resolver
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...**RFK Jr. remains HHS Secretary with strong White House backing.** President Trump has repeatedly voiced support for his health secretary, including through joint appearances and directives aligning on vaccine schedule reviews and related research priorities, even as some advisers sought to moderate messaging ahead of midterms. Kennedy continues directing departmental reorganizations, budget presentations to Congress, and policy implementation on chronic disease and preventive care without signs of resignation or removal. External calls for his departure from critics and healthcare groups have not prompted administration action, and his public statements rule out a 2028 presidential run that might otherwise create exit pressure. Trader consensus at 72% for “No” reflects these structural and political factors limiting near-term departure risk through year-end.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · Atualizado



Cuidado com os links externos.
Cuidado com os links externos.
Frequently Asked Questions